GlassScriptPhysician profile
Marek Solomianko
NPI 1093392086
$1,306.55
in general payments reported to CMS, 2019-2025
12 companies · $832 in 2025
The $832 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $242 · 2023: $113 · 2024: $119 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $294.74 | 2025 | |
| Pfizer INC. | $182.83 | 2022-2023 | |
| Cardiovascular Systems INC. | $154.92 | 2022 | |
| Biosense Webster, INC. | $146.75 | 2025 | Carto 3 |
| Abbott Laboratories | $125.00 | 2025 | Coroflow |
| Alnylam Pharmaceuticals INC. | $120.65 | 2025 | Amvuttra |
| Shockwave Medical, INC | $119.45 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $63.41 | 2025 | Micra |
| Biotronik INC. | $37.95 | 2025 | Amvia Edge |
| Philips North America LLC | $22.06 | 2025 | Fleet Management |
| Astrazeneca Pharmaceuticals LP | $21.00 | 2025 | Lokelma |
| Merck Sharp & Dohme LLC | $17.79 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marek Solomianko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.